DUBLIN–(BUSINESS WIRE)–The “AI In Medical Writing Market Size, Share & Trends Analysis Report By Type (Scientific Writing, Clinical Writing, Type Writing), By End-use (Medical Devices, Pharmaceutical, Biotechnology), By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global AI in the medical writing market is on a trajectory to achieve a significant milestone, projected to reach a valuation of USD 1.76 billion by 2030. Marking a Compound Annual Growth Rate (CAGR) of 12.44% from 2023 to 2030, the market’s expansion is underpinned by the increasing acceptance of machine learning and Artificial Intelligence (AI) in the healthcare sector.
The confluence of factors such as the drive to minimize healthcare costs and heightened Research and Development (R&D) investments by pharmaceutical entities, aiming to curtail expenses, acts as a pivotal driver in propelling the growth of this market.
Navigating the Impact of the Pandemic on Market Dynamics:
The COVID-19 pandemic engendered a moderated effect on the AI in medical writing market. Research and development activities, as well as clinical trials, experienced temporary halts due to the pandemic. Moreover, budget constraints prompted pharmaceutical companies to downsize their investments. The initial stages of the pandemic witnessed a decline in submissions to healthcare journals, hampering market growth.
However, the pandemic’s course highlighted the significance of collaborative endeavors between companies, research groups, and government entities in crafting innovative therapies. This catalyzed the intention of medical device, biotechnology, and life science companies to amplify investments in medical writers, intensifying the demand for AI in the healthcare industry, especially during the pandemic.
AI in Medical Writing Market Highlights:
- The typewriting segment emerged as the market dominator in 2022, commanding a share of 32.89% of the overall revenue. The surge in demand for AI in medical writing within this segment is attributed to the imperative of submitting regulatory documents to authorities.
- The pharmaceutical sector seized the lion’s share of the market, accounting for a revenue share of 33.29% in 2022. This is attributable to robust investments in R&D endeavors to develop novel drugs and treatments, thus fueling the demand for AI in medical writing in this end-use segment.
- Geographically, North America took the lead with a revenue share of 30.12% in 2022. The region’s supremacy can be attributed to its continuous technological advancements, burgeoning healthcare infrastructure, and a notable volume of drug trials and approvals.
Key Topics Explored in the Report:
The report delves into various facets of the AI in medical writing market, encompassing:
- In-depth research methodology and scope, segment definitions, and regional coverage.
- Market variables, trends, and scope analysis, encapsulating drivers, restraints, and industry analysis tools such as Porter’s and Pestel analyses.
- A comprehensive breakdown of the market based on type, including Clinical Writing, Type Writing, Scientific Writing, and Others.
- A detailed exploration of market segments based on end-use, with a focus on Medical Devices, Pharmaceutical, Biotechnology, and Others.
- A comprehensive regional business analysis of the market, offering insights into key countries and their regulatory frameworks, reimbursement scenarios, and country dynamics.
- A competitive landscape evaluation, including company categorization, strategy mapping, and company profiles, featuring prominent players such as Parexel International Corporation, Trilogy Writing & Consulting GmBH, Freyr, Cactus Communications, and GENINVO.
In conclusion, the global AI in medical writing market is undergoing robust growth, propelled by the adoption of machine learning in healthcare, heightened R&D investments, and collaborative initiatives within the industry. With diverse market segments and a competitive landscape, the market is poised to further evolve and shape the healthcare landscape in the years to come.
Companies Mentioned
- Parexel International Corporation
- Trilogy Writing & Consulting GmBH
- Freyr
- Cactus Communications
- GENINVO
For more information about this report visit https://www.researchandmarkets.com/r/n5g4pi
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900